ArticleDiagnostics (Basel, Switzerland)2025

Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation.

Katy Diallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.